Perspective Therapeutics (CATX) Receivables (2011 - 2026)
Perspective Therapeutics' Receivables was $269,000 in Q2 2026, up 19.6% from $225,000 a year earlier and up 363.8% from the prior quarter.
Powered by 
Analysis
Perspective Therapeutics (CATX) Receivables (2011 - 2026) Analysis & Trends
At the end of FY2025, Receivables at Perspective Therapeutics came in at $16,000, down 97.3% from FY2024.
- Receivables has now declined for three consecutive years, with a five-year compound annual growth rate of -62.2% (FY2020 to FY2025).
- In earlier years, Receivables was $603,000 in FY2024 (-48.7%), $1.18 million in FY2023 (-13.9%), $1.37 million in FY2022 and $2.05 million in FY2021 (-1.4%).
- The Q2 2026 figure marks the highest quarterly Receivables since Q4 2024.
- Compared with a year earlier, Receivables was higher in two of the last eight quarters, with an average decline of 36.4%.
- The best year-over-year quarter for Receivables over five years was Q2 2025 (growth of 58.5%); the worst was Q4 2025 (a decline of 97.3%).
- Per Business Quant data, CATX's Receivables in the three quarters before Q2 2026 was $58,000 (Q1 2026), $16,000 (Q4 2025) and $179,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Perspective Therapeutics | 276.29 Mn | 39.39 Mn | - | 269,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 269,000.00 |
| Mar 31, 2026 | 58,000.00 |
| Dec 31, 2025 | 16,000.00 |
| Sep 30, 2025 | 179,000.00 |
| Jun 30, 2025 | 225,000.00 |
| Mar 31, 2025 | 78,000.00 |
| Dec 31, 2024 | 603,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 142,000.00 |
| Mar 31, 2024 | 999,000.00 |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 1.73 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 1.37 Mn |
| Sep 30, 2022 | 1.21 Mn |
| Jun 30, 2022 | 1.63 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 1.65 Mn |
| Sep 30, 2021 | 1.90 Mn |
API Access
Perspective Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CATX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CATX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CATX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();